在Helicobacter pylori管理中不断发展的概念
Steven F Moss1, Shailja C Shah2, Mimi C Tan3
1Brown University, Providence, Rhode Island; Providence VA Medical Center, Providence, Rhode Island.
Gastroenterology
|October 8, 2023
概括
杆菌 (H pylori) 感染是胃癌的主要风险之一,特别是在少数群体中. 系统的查和个性化的治疗方法对于有效的预防至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 杆菌 (H pylori) 是全球胃癌的主要原因.
- 杆菌感染和胃癌不成比例地影响美国的少数民族和移民人口.
- 目前的机会性H pylori查错过了许多无症状感染,延迟了前瘤病变的诊断.
研究的目的:
- 倡导对H pylori查和管理采取系统的方法.
- 为了应对日益下降的根除率和日益增长的抗菌素耐药性.
- 为了强调个性化治疗策略的H pylori感染.
主要方法:
- 审查目前的H pylori病例发现和治疗策略.
- 讨论经验性H.pylori疗法的局限性.
- 突出基于分子的敏感性概况的潜力,以实现个性化治疗.
主要成果:
- 机会性H pylori检测不足以进行全面的胃癌预防.
- 标准的H pylori根除疗法由于抗菌素耐药性而显示出效率下降.
- 分子敏感性测试使得量身定制的H pylori治疗方案成为可能.
结论:
- 需要转向系统的H pylori查和个性化根除.
- 人口层面的查和治疗计划可以减少胃癌的负担.
- 针对高风险的少数群体和边缘化人口是公平预防胃癌的必要条件.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
426
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
426
Peptic Ulcer Disease IV: Management
108
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
108
Gastritis III: Clinical Manifestations and Management
308
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
308
Peptic Ulcer Disease V: Surgical Management and Nursing Care
324
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
324
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
151
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
151
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
443
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
443


